Unknown

Dataset Information

0

Cell-based cccDNA reporter assay combined with functional genomics identifies YBX1 as HBV cccDNA host factor and antiviral candidate target.


ABSTRACT:

Objectives

Chronic hepatitis B virus (HBV) infection is a leading cause of liver disease and hepatocellular carcinoma. A key feature of HBV replication is the synthesis of the covalently close circular (ccc)DNA, not targeted by current treatments and whose elimination would be crucial for viral cure. To date, little is known about cccDNA formation. One major challenge to address this urgent question is the absence of robust models for the study of cccDNA biology.

Design

We established a cell-based HBV cccDNA reporter assay and performed a loss-of-function screen targeting 239 genes encoding the human DNA damage response machinery.

Results

Overcoming the limitations of current models, the reporter assay enables to quantity cccDNA levels using a robust ELISA as a readout. A loss-of-function screen identified 27 candidate cccDNA host factors, including Y box binding protein 1 (YBX1), a DNA binding protein regulating transcription and translation. Validation studies in authentic infection models revealed a robust decrease in HBV cccDNA levels following silencing, providing proof-of-concept for the importance of YBX1 in the early steps of the HBV life cycle. In patients, YBX1 expression robustly correlates with both HBV load and liver disease progression.

Conclusion

Our cell-based reporter assay enables the discovery of HBV cccDNA host factors including YBX1 and is suitable for the characterisation of cccDNA-related host factors, antiviral targets and compounds.

SUBMITTER: Verrier ER 

PROVIDER: S-EPMC10423543 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature

altmetric image

Publications


<h4>Objectives</h4>Chronic hepatitis B virus (HBV) infection is a leading cause of liver disease and hepatocellular carcinoma. A key feature of HBV replication is the synthesis of the covalently close circular (ccc)DNA, not targeted by current treatments and whose elimination would be crucial for viral cure. To date, little is known about cccDNA formation. One major challenge to address this urgent question is the absence of robust models for the study of cccDNA biology.<h4>Design</h4>We establi  ...[more]

Similar Datasets

| S-EPMC5098228 | biostudies-literature
| S-EPMC9579331 | biostudies-literature
| S-EPMC8826402 | biostudies-literature
| S-EPMC9787400 | biostudies-literature
| S-EPMC7487718 | biostudies-literature
| S-EPMC10617570 | biostudies-literature
2021-12-31 | GSE123715 | GEO
| S-EPMC11520515 | biostudies-literature
| S-EPMC5088770 | biostudies-literature
| S-EPMC10311270 | biostudies-literature